Advertisement
Screener

Merck & Co., Inc. (MRK) Other Noncash Income (Expense)

2.2 / 5 stars · 50/112 Roast Me

Merck & Co., Inc. Other Noncash Income (Expense)

Merck & Co., Inc. (MRK) reported Other Noncash Income (Expense) of $61.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Cash Flow › Operating Activities

us-gaap:OtherNoncashIncomeExpense · last filed 2026-08-07

  • Merck & Co., Inc. other noncash income (expense) for the quarter ending 2026-06-30 was $81.00M.
  • Merck & Co., Inc. other noncash income (expense) for the quarter ending 2026-03-31 was -$20.00M.
  • Merck & Co., Inc. other noncash income (expense) for the quarter ending 2025-12-31 was -$118.00M, a 216.83% decline year-over-year.
  • Merck & Co., Inc. other noncash income (expense) for the quarter ending 2025-09-30 was $51.00M.
  • Merck & Co., Inc. other noncash income (expense) for fiscal 2025 was -$511.00M.
  • Merck & Co., Inc. other noncash income (expense) for fiscal 2024 was -$510.00M.
  • Merck & Co., Inc. other noncash income (expense) for fiscal 2023 was -$355.00M.
  • Merck & Co., Inc. other noncash income (expense) for fiscal 2022 was -$1.30B.
Period endOther Noncash Income (Expense) 3 monthOther Noncash Income (Expense) 3 month as first filedOther Noncash Income (Expense) 6 monthOther Noncash Income (Expense) 6 month as first filedOther Noncash Income (Expense) 9 monthOther Noncash Income (Expense) 9 month as first filedOther Noncash Income (Expense) 12 monthOther Noncash Income (Expense) 12 month as first filed
2026-06-30$81.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07
$61.00M
10-Q · filed 2026-08-07
-$57.00M
derived: sum of 3 quarters · filed 2026-08-07
-$6.00M
derived: sum of 4 quarters · filed 2026-08-07
2026-03-31-$20.00M
10-Q · filed 2026-05-04
-$138.00M
derived: sum of 2 quarters · filed 2026-05-04
-$87.00M
derived: sum of 3 quarters · filed 2026-05-04
-$422.00M
derived: sum of 4 quarters · filed 2026-08-07
2025-12-31-$118.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
-$67.00M
derived: sum of 2 quarters · filed 2026-02-24
-$402.00M
derived: sum of 3 quarters · filed 2026-08-07
-$511.00M
10-K · filed 2026-02-24
2025-09-30$51.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
-$284.00M
derived: sum of 2 quarters · filed 2026-08-07
-$393.00M
10-Q · filed 2025-11-05
-$292.00M
derived: sum of 4 quarters · filed 2026-08-07
2025-06-30-$335.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07
-$444.00M
10-Q · filed 2026-08-07
-$343.00M
derived: sum of 3 quarters · filed 2026-08-07
-$780.00M
derived: sum of 4 quarters · filed 2026-08-07
2025-03-31-$109.00M
10-Q · filed 2026-05-04
-$8.00M
derived: sum of 2 quarters · filed 2026-05-04
-$445.00M
derived: sum of 3 quarters · filed 2026-05-04
-$536.00M
derived: sum of 4 quarters · filed 2026-05-04
2024-12-31$101.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
-$336.00M
derived: sum of 2 quarters · filed 2026-02-24
-$427.00M
derived: sum of 3 quarters · filed 2026-02-24
-$510.00M
10-K · filed 2026-02-24
2024-09-30-$437.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
-$528.00M
derived: sum of 2 quarters · filed 2025-11-05
-$611.00M
10-Q · filed 2025-11-05
-$1.05B
derived: sum of 4 quarters · filed 2026-02-24
2024-06-30-$91.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05
-$174.00M
10-Q · filed 2025-08-05
-$610.00M
derived: sum of 3 quarters · filed 2026-02-24
-$524.00M
derived: sum of 4 quarters · filed 2026-02-24
2024-03-31-$83.00M
10-Q · filed 2025-05-02
-$519.00M
derived: sum of 2 quarters · filed 2026-02-24
-$433.00M
derived: sum of 3 quarters · filed 2026-02-24
-$635.00M
derived: sum of 4 quarters · filed 2026-02-24
2023-12-31-$436.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
-$350.00M
derived: sum of 2 quarters · filed 2026-02-24
-$552.00M
derived: sum of 3 quarters · filed 2026-02-24
-$355.00M
10-K · filed 2026-02-24
2023-09-30$86.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06
-$116.00M
derived: sum of 2 quarters · filed 2024-11-06
$81.00M
10-Q · filed 2024-11-06
$94.00M
10-Q · filed 2023-11-03
-$51.00M
derived: sum of 4 quarters · filed 2025-02-25
2023-06-30-$202.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05
-$5.00M
10-Q · filed 2024-08-05
-$137.00M
derived: sum of 3 quarters · filed 2025-02-25
-$507.00M
derived: sum of 4 quarters · filed 2025-02-25
2023-03-31$197.00M
10-Q · filed 2024-05-03
$65.00M
derived: sum of 2 quarters · filed 2025-02-25
-$305.00M
derived: sum of 3 quarters · filed 2025-02-25
-$961.00M
derived: sum of 4 quarters · filed 2025-02-25
2022-12-31-$132.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25
-$502.00M
derived: sum of 2 quarters · filed 2025-02-25
-$1.16B
derived: sum of 3 quarters · filed 2025-02-25
-$1.30B
10-K · filed 2025-02-25
2022-09-30-$370.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03
-$1.03B
derived: sum of 2 quarters · filed 2023-11-03
-$1.17B
10-Q · filed 2023-11-03
-$1.48B
derived: sum of 4 quarters · filed 2024-02-26
2022-06-30-$656.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07
-$799.00M
10-Q · filed 2023-08-07
-$776.00M
10-Q · filed 2022-08-05
-$1.10B
derived: sum of 3 quarters · filed 2024-02-26
-$1.28B
derived: sum of 4 quarters · filed 2024-02-26
2022-03-31-$143.00M
10-Q · filed 2023-05-05
-$449.00M
derived: sum of 2 quarters · filed 2024-02-26
-$620.00M
derived: sum of 3 quarters · filed 2024-02-26
-$712.00M
derived: sum of 4 quarters · filed 2024-02-26
2021-12-31-$306.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26
-$477.00M
derived: sum of 2 quarters · filed 2024-02-26
-$569.00M
derived: sum of 3 quarters · filed 2024-02-26
-$805.00M
10-K · filed 2024-02-26
2021-09-30-$171.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03
-$263.00M
derived: sum of 2 quarters · filed 2022-11-03
-$499.00M
10-Q · filed 2022-11-03
-$1.27B
derived: sum of 4 quarters · filed 2023-02-24
2021-06-30-$92.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05
-$328.00M
10-Q · filed 2022-08-05
$526.00M
10-Q · filed 2021-08-09
-$1.10B
derived: sum of 3 quarters · filed 2023-02-24
-$1.83B
derived: sum of 4 quarters · filed 2023-02-24
2021-03-31-$236.00M
10-Q · filed 2022-05-05
$331.00M
10-Q · filed 2021-05-05
-$1.01B
derived: sum of 2 quarters · filed 2023-02-24
-$1.73B
derived: sum of 3 quarters · filed 2023-02-24
-$1.39B
derived: sum of 4 quarters · filed 2023-02-24
2020-12-31-$775.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24
-$1.50B
derived: sum of 2 quarters · filed 2023-02-24
-$1.15B
derived: sum of 3 quarters · filed 2023-02-24
-$1.29B
10-K · filed 2023-02-24
$49.00M
10-K · filed 2021-02-25
2020-09-30-$723.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05
-$376.00M
derived: sum of 2 quarters · filed 2021-11-05
-$519.00M
10-Q · filed 2021-11-05
$445.00M
10-Q · filed 2020-11-05
-$654.00M
derived: sum of 4 quarters · filed 2022-02-25
2020-06-30$347.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09
$204.00M
10-Q · filed 2021-08-09
$202.00M
10-Q · filed 2020-08-05
$69.00M
derived: sum of 3 quarters · filed 2022-02-25
-$36.00M
derived: sum of 4 quarters · filed 2022-02-25
2020-03-31-$143.00M
10-Q · filed 2021-05-05
-$278.00M
derived: sum of 2 quarters · filed 2022-02-25
-$383.00M
derived: sum of 3 quarters · filed 2022-02-25
-$377.00M
derived: sum of 4 quarters · filed 2022-02-25
2019-12-31-$135.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25
-$240.00M
derived: sum of 2 quarters · filed 2022-02-25
-$234.00M
derived: sum of 3 quarters · filed 2022-02-25
-$354.00M
10-K · filed 2022-02-25
-$184.00M
10-K · filed 2020-02-26
2019-09-30-$105.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
-$99.00M
derived: sum of 2 quarters · filed 2020-11-05
-$219.00M
10-Q · filed 2020-11-05
-$709.00M
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30$6.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05
-$114.00M
10-Q · filed 2020-08-05
-$604.00M
derived: sum of 3 quarters · filed 2021-02-25
-$727.00M
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31-$120.00M
10-Q · filed 2020-05-06
-$610.00M
derived: sum of 2 quarters · filed 2021-02-25
-$733.00M
derived: sum of 3 quarters · filed 2021-02-25
-$1.05B
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31-$490.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
-$613.00M
derived: sum of 2 quarters · filed 2021-02-25
-$928.00M
derived: sum of 3 quarters · filed 2021-02-25
-$978.00M
10-K · filed 2021-02-25
2018-09-30-$123.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05
-$438.00M
derived: sum of 2 quarters · filed 2019-11-05
-$488.00M
10-Q · filed 2019-11-05
-$585.00M
10-Q · filed 2018-11-06
-$709.00M
derived: sum of 4 quarters · filed 2020-02-26
2018-06-30-$315.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06
-$365.00M
10-Q · filed 2019-08-06
-$429.00M
10-Q · filed 2018-08-07
-$586.00M
derived: sum of 3 quarters · filed 2020-02-26
-$492.00M
derived: sum of 4 quarters · filed 2020-02-26
2018-03-31-$50.00M
10-Q · filed 2019-05-08
-$271.00M
derived: sum of 2 quarters · filed 2020-02-26
-$177.00M
derived: sum of 3 quarters · filed 2020-02-26
-$268.00M
derived: sum of 4 quarters · filed 2020-02-26
2017-12-31-$221.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26
-$127.00M
derived: sum of 2 quarters · filed 2020-02-26
-$218.00M
derived: sum of 3 quarters · filed 2020-02-26
-$190.00M
10-K · filed 2020-02-26
-$269.00M
10-K · filed 2018-02-27
2017-09-30$94.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06
$3.00M
derived: sum of 2 quarters · filed 2018-11-06
$31.00M
10-Q · filed 2018-11-06
$18.00M
derived: sum of 4 quarters · filed 2019-02-27
2017-06-30-$91.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07
-$63.00M
10-Q · filed 2018-08-07
-$76.00M
derived: sum of 3 quarters · filed 2019-02-27
-$110.00M
derived: sum of 4 quarters · filed 2019-02-27
2017-03-31$28.00M
10-Q · filed 2018-05-08
$15.00M
derived: sum of 2 quarters · filed 2019-02-27
-$19.00M
derived: sum of 3 quarters · filed 2019-02-27
-$103.00M
derived: sum of 4 quarters · filed 2019-02-27
2016-12-31-$13.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27
-$47.00M
derived: sum of 2 quarters · filed 2019-02-27
-$131.00M
derived: sum of 3 quarters · filed 2019-02-27
-$213.00M
10-K · filed 2019-02-27
-$313.00M
10-K · filed 2017-02-28
2016-09-30-$34.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07
-$118.00M
derived: sum of 2 quarters · filed 2017-11-07
-$200.00M
10-Q · filed 2017-11-07
-$247.00M
10-Q · filed 2016-11-07
-$259.00M
derived: sum of 4 quarters · filed 2018-02-27
2016-06-30-$84.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08
-$166.00M
10-Q · filed 2017-08-08
-$197.00M
10-Q · filed 2016-08-08
-$225.00M
derived: sum of 3 quarters · filed 2018-02-27
-$351.00M
derived: sum of 4 quarters · filed 2018-02-27
2016-03-31-$82.00M
10-Q · filed 2017-05-09
-$97.00M
10-Q · filed 2016-05-09
-$141.00M
derived: sum of 2 quarters · filed 2018-02-27
-$267.00M
derived: sum of 3 quarters · filed 2018-02-27
-$405.00M
derived: sum of 4 quarters · filed 2018-02-27
2015-12-31-$59.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27
-$185.00M
derived: sum of 2 quarters · filed 2018-02-27
-$323.00M
derived: sum of 3 quarters · filed 2018-02-27
-$874.00M
10-K · filed 2018-02-27
-$757.00M
10-K · filed 2016-02-26
2015-09-30-$126.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07
-$264.00M
derived: sum of 2 quarters · filed 2016-11-07
-$815.00M
10-Q · filed 2016-11-07
-$697.00M
10-Q · filed 2015-11-05
-$1.29B
derived: sum of 4 quarters · filed 2017-02-28
2015-06-30-$138.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08
-$689.00M
10-Q · filed 2016-08-08
-$577.00M
10-Q · filed 2015-08-06
-$1.17B
derived: sum of 3 quarters · filed 2017-02-28
-$915.00M
derived: sum of 4 quarters · filed 2017-02-28
2015-03-31-$551.00M
10-Q · filed 2016-05-09
-$1.03B
derived: sum of 2 quarters · filed 2017-02-28
-$777.00M
derived: sum of 3 quarters · filed 2017-02-28
-$700.00M
derived: sum of 4 quarters · filed 2017-02-28
2014-12-31-$480.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28
-$226.00M
derived: sum of 2 quarters · filed 2017-02-28
-$149.00M
derived: sum of 3 quarters · filed 2017-02-28
-$34.00M
10-K · filed 2017-02-28
$95.00M
10-K · filed 2015-02-27
2014-09-30$254.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
$331.00M
derived: sum of 2 quarters · filed 2015-11-05
$446.00M
10-Q · filed 2015-11-05
$50.00M
10-Q · filed 2014-11-10
$474.00M
derived: sum of 4 quarters · filed 2016-02-26
2014-06-30$77.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
$192.00M
10-Q · filed 2015-08-06
$220.00M
derived: sum of 3 quarters · filed 2016-02-26
$305.00M
derived: sum of 4 quarters · filed 2016-02-26
2014-03-31$115.00M
10-Q · filed 2015-05-07
$143.00M
derived: sum of 2 quarters · filed 2016-02-26
$228.00M
derived: sum of 3 quarters · filed 2016-02-26
$182.00M
derived: sum of 4 quarters · filed 2016-02-26
2013-12-31$28.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26
$113.00M
derived: sum of 2 quarters · filed 2016-02-26
$67.00M
derived: sum of 3 quarters · filed 2016-02-26
-$259.00M
10-K · filed 2016-02-26
-$399.00M
10-K · filed 2014-02-27
2013-09-30$85.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10
$39.00M
derived: sum of 2 quarters · filed 2014-11-10
-$287.00M
10-Q · filed 2014-11-10
-$349.00M
derived: sum of 4 quarters · filed 2015-02-27
2013-06-30-$46.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07
-$372.00M
10-Q · filed 2014-08-07
-$434.00M
derived: sum of 3 quarters · filed 2015-02-27
-$257.00M
derived: sum of 4 quarters · filed 2015-02-27
2013-03-31-$326.00M
10-Q · filed 2014-05-08
-$388.00M
derived: sum of 2 quarters · filed 2015-02-27
-$211.00M
derived: sum of 3 quarters · filed 2015-02-27
-$283.00M
derived: sum of 4 quarters · filed 2015-02-27
2012-12-31-$62.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27
$115.00M
derived: sum of 2 quarters · filed 2015-02-27
$43.00M
derived: sum of 3 quarters · filed 2015-02-27
-$28.00M
10-K · filed 2015-02-27
2012-09-30$177.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07
$105.00M
derived: sum of 2 quarters · filed 2013-11-07
$34.00M
10-Q · filed 2013-11-07
-$496.00M
derived: sum of 4 quarters · filed 2014-02-27
2012-06-30-$72.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07
-$143.00M
10-Q · filed 2013-08-07
-$673.00M
derived: sum of 3 quarters · filed 2014-02-27
-$922.00M
derived: sum of 4 quarters · filed 2014-02-27
2012-03-31-$71.00M
10-Q · filed 2013-05-09
-$601.00M
derived: sum of 2 quarters · filed 2014-02-27
-$850.00M
derived: sum of 3 quarters · filed 2014-02-27
-$616.00M
derived: sum of 4 quarters · filed 2014-02-27
2011-12-31-$530.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27
-$779.00M
derived: sum of 2 quarters · filed 2014-02-27
-$545.00M
derived: sum of 3 quarters · filed 2014-02-27
-$323.00M
10-K · filed 2014-02-27
2011-09-30-$249.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09
-$15.00M
derived: sum of 2 quarters · filed 2012-11-09
$207.00M
10-Q · filed 2012-11-09
$57.00M
derived: sum of 4 quarters · filed 2013-02-28
2011-06-30$234.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07
$456.00M
10-Q · filed 2012-08-07
$306.00M
derived: sum of 3 quarters · filed 2013-02-28
$489.00M
derived: sum of 4 quarters · filed 2013-02-28
2011-03-31$222.00M
10-Q · filed 2012-05-08
$72.00M
derived: sum of 2 quarters · filed 2013-02-28
$255.00M
derived: sum of 3 quarters · filed 2013-02-28
2010-12-31-$150.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28
$33.00M
derived: sum of 2 quarters · filed 2013-02-28
-$377.00M
10-K · filed 2013-02-28
2010-09-30$183.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08
-$227.00M
10-Q · filed 2011-11-08
2010-06-30-$410.00M
10-Q · filed 2011-08-08
2009-12-31$535.00M
10-K · filed 2012-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
AbbVie Inc. (ABBV)United States$468.180B70.37
ABBOTT LABORATORIES (ABT)United States$176.045B28.47
PFIZER INC (PFE)United States$162.042B31.94
VERTEX PHARMACEUTICALS INC / MA (VRTX)United States$132.481B28.56
BRISTOL MYERS SQUIBB CO (BMY)United States$125.637B12.67
JOHNSON & JOHNSON (JNJ)United States$652.528B29.10
REGENERON PHARMACEUTICALS, INC. (REGN)United States$74.751B21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Zoetis Inc. (ZTS)United States$29.045B11.38
INSMED Inc (INSM)United States$26.566B-26.60